Posted on:Weil in the News
Weil is representing Baring Private Equity Asia (BPEA) in its sale of 100% of China-headquartered HCP Packaging (HCP), a global leader in the design, development and manufacture of cosmetic packaging, to global investment firm Carlyle. Equity for this transaction will come from affiliates of Carlyle Asia Partners and Carlyle Japan Partners, which are two of Carlyle’s buyout funds in Asia. The transaction is expected to close in Q3 2022 and is subject to customary regulatory approvals.
HCP is one of the world’s largest beauty packaging providers with 10 state-of-the-art production and manufacturing facilities across China, the United States, Mexico and Europe. It works with more than 250 leading cosmetics, skincare and fragrance brands, including Estée Lauder, L’Oréal, Shiseido and many others, on innovative and sustainable packaging solutions.
The Weil team was led by Hong Kong Private Equity partners Tim Gardner, Chris Welty and Sandy Lin and included counsel Kevin Yao and Jie Yuan and associates Jacky Sin, Max Chu, Graham Price, Hongzheng Huang and Connie Ng, with additional support provided by Weil lawyers in the United States, France, Germany and the United Kingdom.